$EFSI
EAGLE FINANCIAL SERVICES INC Stock $efsi

$efsi Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-Q Financial Statement

#000088064116000183 Filed on November 14, 2016

Income Statement

Concept	2016 Q4	2016 Q3	2015 Q3
Revenue	$6.443M	$6.279M	$6.265M
YoY Change	4.44%	0.22%	0.19%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$280.0K	$290.0K	$260.0K
YoY Change	3.7%	11.54%	13.04%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense		$242.0K	$321.0K
YoY Change		-24.61%	-33.13%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$2.578M	$1.978M	$4.666M
YoY Change	53.64%	-57.61%	143.91%
Income Tax	$770.0K	$548.0K	$1.377M
% Of Pretax Income	29.87%	27.7%	29.51%
Net Earnings	$1.805M	$1.430M	$3.289M
YoY Change	33.21%	-56.52%	137.47%
Net Earnings / Revenue	28.01%	22.77%	52.5%
Basic Earnings Per Share	$0.52	$0.40	$0.94
Diluted Earnings Per Share	$0.52	$0.40	$0.94
COMMON SHARES
Basic Shares Outstanding	3.482M shares	3.528M shares	3.503M shares
Diluted Shares Outstanding		3.528M shares	3.503M shares

Balance Sheet

Concept	2016 Q4	2016 Q3	2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$35.28M	$19.39M	$16.94M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$20.17M	$20.28M	$20.92M
YoY Change	-3.79%	-3.09%	12.93%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$700.1M	$668.4M	$638.1M
YoY Change	7.18%	4.76%	5.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$16.90M	$6.700M	$2.600M
YoY Change	293.02%	157.69%	0.0%
Total Long-Term Liabilities	$16.90M	$6.700M	$2.600M
YoY Change	293.02%	157.69%	-73.47%
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities	$16.90M	$6.700M	$2.600M
Total Liabilities	$620.7M	$587.7M	$560.5M
YoY Change	7.94%	4.86%	4.77%
SHAREHOLDERS EQUITY
Retained Earnings	$58.17M	$57.13M	$54.03M
YoY Change	6.37%	5.73%	10.64%
Common Stock	$8.633M	$8.666M	$8.723M
YoY Change	-1.43%	-0.65%	1.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$79.42M	$80.71M	$77.61M
YoY Change
Total Liabilities & Shareholders Equity	$700.1M	$668.4M	$638.1M
YoY Change	7.18%	4.76%	5.25%

Cashflow Statement

Concept	2016 Q4	2016 Q3	2015 Q3
OPERATING ACTIVITIES
Net Income	$1.805M	$1.430M	$3.289M
YoY Change	33.21%	-56.52%	137.47%
Depreciation, Depletion And Amortization	$280.0K	$290.0K	$260.0K
YoY Change	3.7%	11.54%	13.04%
Cash From Operating Activities	$3.560M	$1.700M	$3.460M
YoY Change	64.81%	-50.87%	147.14%
INVESTING ACTIVITIES
Capital Expenditures	-$130.0K	-$20.00K	-$340.0K
YoY Change	-62.86%	-94.12%	-82.47%
Acquisitions
YoY Change
Other Investing Activities	-$9.210M	$490.0K	$100.0K
YoY Change	16.88%	390.0%	-87.8%
Cash From Investing Activities	-$9.320M	$460.0K	-$250.0K
YoY Change	13.24%	-284.0%	-77.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	21.65M	-12.36M	1.590M
YoY Change	75.45%	-877.36%	-40.0%
NET CHANGE
Cash From Operating Activities	3.560M	1.700M	3.460M
Cash From Investing Activities	-9.320M	460.0K	-250.0K
Cash From Financing Activities	21.65M	-12.36M	1.590M
Net Change In Cash	15.89M	-10.20M	4.800M
YoY Change	153.43%	-312.5%	63.82%
FREE CASH FLOW
Cash From Operating Activities	$3.560M	$1.700M	$3.460M
Capital Expenditures	-$130.0K	-$20.00K	-$340.0K
Free Cash Flow	$3.690M	$1.720M	$3.800M
YoY Change	47.01%	-54.74%	13.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000880641
CY2016Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3481749	shares
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Registrant Name EntityRegistrantName	EAGLE FINANCIAL SERVICES INC
	efsi	Amortization Of Intangible And Other Assets AmortizationOfIntangibleAndOtherAssets	154000	USD
	efsi	Amortization Of Intangible And Other Assets AmortizationOfIntangibleAndOtherAssets	137000	USD
CY2015Q3	efsi	Atm Network Fees AtmNetworkFees	246000	USD
	efsi	Atm Network Fees AtmNetworkFees	595000	USD
CY2016Q3	efsi	Atm Network Fees AtmNetworkFees	242000	USD
	efsi	Atm Network Fees AtmNetworkFees	678000	USD
CY2015Q3	efsi	Bank Franchise Tax BankFranchiseTax	131000	USD
	efsi	Bank Franchise Tax BankFranchiseTax	374000	USD
CY2016Q3	efsi	Bank Franchise Tax BankFranchiseTax	125000	USD
	efsi	Bank Franchise Tax BankFranchiseTax	376000	USD
	efsi	Change In Market Value Of Interest Rate Swap Non Cash ChangeInMarketValueOfInterestRateSwapNonCash	52000	USD
	efsi	Change In Market Value Of Interest Rate Swap Non Cash ChangeInMarketValueOfInterestRateSwapNonCash	0	USD
	efsi	Changes In Shareholder Equity Retirement Of Common Stock ChangesInShareholderEquityRetirementOfCommonStock	-1648000	USD
CY2016Q3	efsi	Consolidated Financial Ownership Wholly Owned Subsidiary Percentage ConsolidatedFinancialOwnershipWhollyOwnedSubsidiaryPercentage	1.00
CY2015Q3	efsi	Costtoterminateoperatinglease Costtoterminateoperatinglease	0	USD
	efsi	Costtoterminateoperatinglease Costtoterminateoperatinglease	520000	USD
CY2016Q3	efsi	Costtoterminateoperatinglease Costtoterminateoperatinglease	0	USD
	efsi	Costtoterminateoperatinglease Costtoterminateoperatinglease	0	USD
	efsi	Deferred Compensation Arrangements Unrecognized Compensation Cost Related To Unvested Restricted Stock DeferredCompensationArrangementsUnrecognizedCompensationCostRelatedToUnvestedRestrictedStock	134000	USD
	efsi	Number Of Retired Employees Provided Health Care And Life Insurance NumberOfRetiredEmployeesProvidedHealthCareAndLifeInsurance	9
CY2015Q3	efsi	Other Comprehensive Income Loss Tax Effect Of Current Period Changes OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges	340000	USD
	efsi	Other Comprehensive Income Loss Tax Effect Of Current Period Changes OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges	41000	USD
CY2016Q3	efsi	Other Comprehensive Income Loss Tax Effect Of Current Period Changes OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges	-40000	USD
	efsi	Other Comprehensive Income Loss Tax Effect Of Current Period Changes OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges	471000	USD
CY2015Q4	efsi	Other Real Estate Gross OtherRealEstateGross	806000	USD
CY2016Q3	efsi	Other Real Estate Gross OtherRealEstateGross	863000	USD
CY2015Q3	efsi	Other Real Estate Owned Expense OtherRealEstateOwnedExpense	63000	USD
CY2015Q4	efsi	Financing Receivable Modifications Nonaccrual Numberof Contracts FinancingReceivableModificationsNonaccrualNumberofContracts	2
CY2016Q3	efsi	Financing Receivable Modifications Nonaccrual Numberof Contracts FinancingReceivableModificationsNonaccrualNumberofContracts	5
CY2015Q4	efsi	Financing Receivable Modifications Nonaccrual Recorded Investment FinancingReceivableModificationsNonaccrualRecordedInvestment	526000	USD
CY2016Q3	efsi	Financing Receivable Modifications Nonaccrual Recorded Investment FinancingReceivableModificationsNonaccrualRecordedInvestment	1340000	USD
CY2015Q3	efsi	Gainonredemptionoftrustpreferredcapitalnotes Gainonredemptionoftrustpreferredcapitalnotes	2424000	USD
	efsi	Gainonredemptionoftrustpreferredcapitalnotes Gainonredemptionoftrustpreferredcapitalnotes	2424000	USD
CY2016Q3	efsi	Gainonredemptionoftrustpreferredcapitalnotes Gainonredemptionoftrustpreferredcapitalnotes	0	USD
	efsi	Gainonredemptionoftrustpreferredcapitalnotes Gainonredemptionoftrustpreferredcapitalnotes	0	USD
	efsi	Increase Decrease In Federal Home Loan Bank Advances Net IncreaseDecreaseInFederalHomeLoanBankAdvancesNet	10000000	USD
	efsi	Increase Decrease In Federal Home Loan Bank Advances Net IncreaseDecreaseInFederalHomeLoanBankAdvancesNet	20000000	USD
CY2015Q3	efsi	Interest On Interest Rate Swap InterestOnInterestRateSwap	46000	USD
	efsi	Interest On Interest Rate Swap InterestOnInterestRateSwap	137000	USD
CY2016Q3	efsi	Interest On Interest Rate Swap InterestOnInterestRateSwap	38000	USD
	efsi	Interest On Interest Rate Swap InterestOnInterestRateSwap	118000	USD
	efsi	Issuance Of Common Stock Employee Benefit Plan IssuanceOfCommonStockEmployeeBenefitPlan	166000	USD
	efsi	Issuance Of Common Stock Employee Benefit Plan IssuanceOfCommonStockEmployeeBenefitPlan	58000	USD
	efsi	Other Real Estate Owned Expense OtherRealEstateOwnedExpense	83000	USD
CY2016Q3	efsi	Other Real Estate Owned Expense OtherRealEstateOwnedExpense	50000	USD
	efsi	Other Real Estate Owned Expense OtherRealEstateOwnedExpense	52000	USD
	efsi	Paymentsfor Retirement Of Common Stock PaymentsforRetirementOfCommonStock	0	USD
	efsi	Paymentsfor Retirement Of Common Stock PaymentsforRetirementOfCommonStock	1648000	USD
	efsi	Period Past Due Loan Considered Payment Default PeriodPastDueLoanConsideredPaymentDefault	P30D
	efsi	Post Retirement Benefits Age Eligibility Requirement PostRetirementBenefitsAgeEligibilityRequirement	P65Y
	efsi	Post Retirement Benefits Service Eligibility Requirement PostRetirementBenefitsServiceEligibilityRequirement	P15Y
	efsi	Redemptionoftrustpreferredcapitalnotes Redemptionoftrustpreferredcapitalnotes	4793000	USD
	efsi	Redemptionoftrustpreferredcapitalnotes Redemptionoftrustpreferredcapitalnotes	0	USD
CY2015Q4	efsi	Time Deposits250000or More TimeDeposits250000orMore	11927000	USD
CY2016Q3	efsi	Time Deposits250000or More TimeDeposits250000orMore	20920000	USD
CY2015Q4	efsi	Time Deposits Lessthan250000 TimeDepositsLessthan250000	80444000	USD
CY2016Q3	efsi	Time Deposits Lessthan250000 TimeDepositsLessthan250000	67942000	USD
CY2015Q3	efsi	Troubled Debt Restructuring Modifications Number Of Contracts TroubledDebtRestructuringModificationsNumberOfContracts	1
	efsi	Troubled Debt Restructuring Modifications Number Of Contracts TroubledDebtRestructuringModificationsNumberOfContracts	2
CY2016Q3	efsi	Troubled Debt Restructuring Modifications Number Of Contracts TroubledDebtRestructuringModificationsNumberOfContracts	2
	efsi	Troubled Debt Restructuring Modifications Number Of Contracts TroubledDebtRestructuringModificationsNumberOfContracts	4
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-191000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-287000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1315000	USD
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	734000	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1393000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1051000	USD
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2044000	USD
CY2016Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1965000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13730000	USD
CY2016Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	12951000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	227000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	220000	USD
	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	4000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2015Q4	us-gaap	Assets Assets	653272000	USD
CY2016Q3	us-gaap	Assets Assets	668421000	USD
CY2015Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	105823000	USD
CY2016Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	105554000	USD
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	105823000	USD
CY2016Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	105554000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1937000	USD
CY2016Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2960000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	402000	USD
CY2016Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	40000	USD
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	104288000	USD
CY2016Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	102634000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	43000	USD
CY2016Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	402000	USD
CY2016Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	40000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	46860000	USD
CY2016Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	8237000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	359000	USD
CY2016Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	40000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	43273000	USD
CY2016Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	8237000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	3587000	USD
CY2016Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	116000	USD
	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	94000	USD
CY2015Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	45
CY2016Q3	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	13
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34564000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16941000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23221000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19394000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-17623000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-3827000	USD
CY2015Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	11082000	USD
CY2016Q3	us-gaap	Cash And Due From Banks CashAndDueFromBanks	9902000	USD
CY2015Q4	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	23221000	USD
CY2016Q3	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	19394000	USD
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.6
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.6
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2.50
CY2016Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2.50
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2016Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3517648	shares
CY2016Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3486425	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	8758000	USD
CY2016Q3	us-gaap	Common Stock Value CommonStockValue	8666000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3948000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5620000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1351000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5479000	USD
CY2015Q4	us-gaap	Deposits Domestic DepositsDomestic	550718000	USD
CY2016Q3	us-gaap	Deposits Domestic DepositsDomestic	581023000	USD
	us-gaap	Depreciation Depreciation	619000	USD
	us-gaap	Depreciation Depreciation	698000	USD
	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	30000	USD
	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	113000	USD
CY2015Q3	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	156000	USD
	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	190000	USD
CY2016Q3	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	0	USD
	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	0	USD
CY2015Q3	us-gaap	Dividend Income Operating DividendIncomeOperating	42000	USD
	us-gaap	Dividend Income Operating DividendIncomeOperating	75000	USD
CY2016Q3	us-gaap	Dividend Income Operating DividendIncomeOperating	22000	USD
	us-gaap	Dividend Income Operating DividendIncomeOperating	68000	USD
	us-gaap	Dividends Common Stock DividendsCommonStock	2091000	USD
	us-gaap	Dividends Common Stock DividendsCommonStock	2122000	USD
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.94
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.59
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.29
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.94
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.59
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.40
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
CY2015Q3	us-gaap	Equipment Expense EquipmentExpense	312000	USD
	us-gaap	Equipment Expense EquipmentExpense	718000	USD
CY2016Q3	us-gaap	Equipment Expense EquipmentExpense	361000	USD
	us-gaap	Equipment Expense EquipmentExpense	1026000	USD
CY2015Q3	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	108000	USD
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	319000	USD
CY2016Q3	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	103000	USD
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	307000	USD
CY2015Q4	us-gaap	Federal Funds Sold FederalFundsSold	0	USD
CY2016Q3	us-gaap	Federal Funds Sold FederalFundsSold	108000	USD
CY2015Q4	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	20000000	USD
CY2016Q3	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	0	USD
CY2015Q3	us-gaap	Fees And Commissions Depositor Accounts FeesAndCommissionsDepositorAccounts	329000	USD
	us-gaap	Fees And Commissions Depositor Accounts FeesAndCommissionsDepositorAccounts	926000	USD
CY2016Q3	us-gaap	Fees And Commissions Depositor Accounts FeesAndCommissionsDepositorAccounts	321000	USD
	us-gaap	Fees And Commissions Depositor Accounts FeesAndCommissionsDepositorAccounts	901000	USD
CY2015Q3	us-gaap	Fees And Commissions Fiduciary And Trust Activities FeesAndCommissionsFiduciaryAndTrustActivities	319000	USD
	us-gaap	Fees And Commissions Fiduciary And Trust Activities FeesAndCommissionsFiduciaryAndTrustActivities	1103000	USD
CY2016Q3	us-gaap	Fees And Commissions Fiduciary And Trust Activities FeesAndCommissionsFiduciaryAndTrustActivities	315000	USD
	us-gaap	Fees And Commissions Fiduciary And Trust Activities FeesAndCommissionsFiduciaryAndTrustActivities	1023000	USD
CY2015Q3	us-gaap	Fees And Commissions Other FeesAndCommissionsOther	919000	USD
	us-gaap	Fees And Commissions Other FeesAndCommissionsOther	2605000	USD
CY2016Q3	us-gaap	Fees And Commissions Other FeesAndCommissionsOther	999000	USD
	us-gaap	Fees And Commissions Other FeesAndCommissionsOther	2820000	USD
	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	688000	USD
CY2014Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	5080000	USD
CY2015Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	5164000	USD
CY2015Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	4959000	USD
CY2016Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	4658000	USD
CY2015Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	4383000	USD
CY2016Q3	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	4141000	USD
CY2015Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	576000	USD
CY2016Q3	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	517000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	499000	USD
CY2015	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	562000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	217000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	438000	USD
CY2015	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	456000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	472000	USD
CY2015Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	481570000	USD
CY2016Q3	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	498452000	USD
CY2015Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	14003000	USD
CY2016Q3	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	15860000	USD
CY2015	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	24
	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	27
CY2015Q3	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	169000	USD
CY2016Q3	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	129000	USD
	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	961000	USD
CY2015Q3	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	169000	USD
	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	688000	USD
CY2016Q3	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	160000	USD
	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	992000	USD
CY2015Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	7500000	USD
CY2016Q3	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	7700000	USD
CY2015Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	307000	USD
CY2016Q3	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	300000	USD
CY2015Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	489679000	USD
CY2016Q3	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	507288000	USD
CY2015Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	5285000	USD
CY2016Q3	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	7305000	USD
CY2015Q4	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	5894000	USD
CY2016Q3	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	7024000	USD
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	0	USD
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-1000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	5000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-10000	USD
CY2015Q3	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	20000	USD
	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	116000	USD
CY2016Q3	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	8000	USD
	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	94000	USD
CY2015Q3	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	11000	USD
	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	-81000	USD
CY2016Q3	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	12000	USD
	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	-35000	USD
CY2015	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	14350000	USD
CY2016Q3	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	15970000	USD
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	16119000	USD
CY2015	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	404000	USD
CY2016Q3	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	113000	USD
	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	394000	USD
CY2015Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	14026000	USD
CY2016Q3	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	15883000	USD
CY2015Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	576000	USD
CY2016Q3	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	517000	USD
CY2015Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	14999000	USD
CY2016Q3	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	16657000	USD
CY2015	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	8571000	USD
	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	11850000	USD
CY2015	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	183000	USD
	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	261000	USD
CY2015Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	8334000	USD
CY2016Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	11687000	USD
CY2015Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	8960000	USD
CY2016Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	12078000	USD
CY2015	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	5779000	USD
	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	4269000	USD
CY2015	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	221000	USD
	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	133000	USD
CY2015Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	5692000	USD
CY2016Q3	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	4196000	USD
CY2015Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	6039000	USD
CY2016Q3	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	4579000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4666000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	7652000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1978000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	6345000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1377000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2110000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	548000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1780000	USD
	us-gaap	Interest Expense Deposits InterestExpenseDeposits	551000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	583000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	23483000	USD
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	33814000	USD
	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	6000	USD
	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	2358000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-437000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1922000	USD
	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	572000	USD
	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	-3509000	USD
CY2015Q3	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	134000	USD
	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	547000	USD
CY2016Q3	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	180000	USD
	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	447000	USD
CY2015Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	6265000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	18324000	USD
CY2016Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	6279000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	19342000	USD
CY2015Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	5540000	USD
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	16278000	USD
CY2016Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	5658000	USD
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	17250000	USD
CY2015Q4	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	272214000	USD
CY2016Q3	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	288535000	USD
CY2015Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	12139000	USD
CY2016Q3	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	9384000	USD
CY2015Q4	us-gaap	Interest Bearing Domestic Deposit Money Market InterestBearingDomesticDepositMoneyMarket	105560000	USD
CY2016Q3	us-gaap	Interest Bearing Domestic Deposit Money Market InterestBearingDomesticDepositMoneyMarket	119313000	USD
CY2015Q4	us-gaap	Interest Bearing Domestic Deposit Negotiable Order Of Withdrawal Now InterestBearingDomesticDepositNegotiableOrderOfWithdrawalNOW	86199000	USD
CY2016Q3	us-gaap	Interest Bearing Domestic Deposit Negotiable Order Of Withdrawal Now InterestBearingDomesticDepositNegotiableOrderOfWithdrawalNOW	78605000	USD
CY2015Q4	us-gaap	Interest Bearing Domestic Deposit Savings InterestBearingDomesticDepositSavings	80455000	USD
CY2016Q3	us-gaap	Interest Bearing Domestic Deposit Savings InterestBearingDomesticDepositSavings	90617000	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	321000	USD
	us-gaap	Interest Expense InterestExpense	1045000	USD
CY2016Q3	us-gaap	Interest Expense InterestExpense	242000	USD
	us-gaap	Interest Expense InterestExpense	846000	USD
CY2015Q3	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	69000	USD
	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	269000	USD
CY2016Q3	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	7000	USD
	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	136000	USD
CY2015Q3	us-gaap	Interest Expense Deposits InterestExpenseDeposits	185000	USD
CY2016Q3	us-gaap	Interest Expense Deposits InterestExpenseDeposits	196000	USD
	us-gaap	Interest Expense Deposits InterestExpenseDeposits	591000	USD
CY2015Q3	us-gaap	Interest Expense Federal Funds Purchased And Securities Sold Under Agreements To Repurchase InterestExpenseFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase	9000	USD
	us-gaap	Interest Expense Federal Funds Purchased And Securities Sold Under Agreements To Repurchase InterestExpenseFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase	10000	USD
CY2015Q3	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	244000	USD
	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	733000	USD
CY2016Q3	us-gaap	Interest Expense Federal Funds Purchased And Securities Sold Under Agreements To Repurchase InterestExpenseFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase	1000	USD
	us-gaap	Interest Expense Federal Funds Purchased And Securities Sold Under Agreements To Repurchase InterestExpenseFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase	1000	USD
CY2015Q3	us-gaap	Interest Expense Trust Preferred Securities InterestExpenseTrustPreferredSecurities	12000	USD
	us-gaap	Interest Expense Trust Preferred Securities InterestExpenseTrustPreferredSecurities	78000	USD
CY2016Q3	us-gaap	Interest Expense Trust Preferred Securities InterestExpenseTrustPreferredSecurities	0	USD
	us-gaap	Interest Expense Trust Preferred Securities InterestExpenseTrustPreferredSecurities	0	USD
CY2015Q3	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	2000	USD
	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	19000	USD
CY2016Q3	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	15000	USD
	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	53000	USD
CY2015Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	6354000	USD
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	17256000	USD
CY2016Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	6162000	USD
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	18542000	USD
CY2015Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	5944000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	17279000	USD
CY2016Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	6037000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	18496000	USD
CY2016Q3	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	230000	USD
	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	695000	USD
CY2015Q3	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	437000	USD
	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	1219000	USD
CY2016Q3	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	354000	USD
	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	1276000	USD
	us-gaap	Interest Paid InterestPaid	1141000	USD
	us-gaap	Interest Paid InterestPaid	869000	USD
CY2015Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3090000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	9197000	USD
CY2016Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3251000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	9828000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	575051000	USD
CY2016Q3	us-gaap	Liabilities Liabilities	587714000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	653272000	USD
CY2016Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	668421000	USD
CY2015Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	149000	USD
CY2016Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	36000	USD
CY2015Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	4959000	USD
CY2016Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	4658000	USD
CY2015Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	495573000	USD
CY2016Q3	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	514312000	USD
CY2015Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	490614000	USD
CY2016Q3	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	509654000	USD
	us-gaap	Loss On Cash Flow Hedge Ineffectiveness LossOnCashFlowHedgeIneffectiveness	237000	USD
	us-gaap	Loss On Cash Flow Hedge Ineffectiveness LossOnCashFlowHedgeIneffectiveness	0	USD
CY2015Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	155000	USD
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	458000	USD
CY2016Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	151000	USD
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	498000	USD
CY2015Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	0	USD
CY2016Q2	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7888000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7092000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-30506000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17055000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4995000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6136000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	3289000	USD
	us-gaap	Net Income Loss NetIncomeLoss	5542000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	1430000	USD
	us-gaap	Net Income Loss NetIncomeLoss	4565000	USD
CY2015Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	186133000	USD
CY2016Q3	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	203626000	USD
CY2015Q3	us-gaap	Noninterest Expense NoninterestExpense	5518000	USD
	us-gaap	Noninterest Expense NoninterestExpense	16707000	USD
CY2016Q3	us-gaap	Noninterest Expense NoninterestExpense	5871000	USD
	us-gaap	Noninterest Expense NoninterestExpense	17257000	USD
CY2015Q3	us-gaap	Noninterest Income NoninterestIncome	3830000	USD
	us-gaap	Noninterest Income NoninterestIncome	7103000	USD
CY2016Q3	us-gaap	Noninterest Income NoninterestIncome	1687000	USD
	us-gaap	Noninterest Income NoninterestIncome	5060000	USD
CY2015Q3	us-gaap	Noninterest Income Other NoninterestIncomeOther	-181000	USD
	us-gaap	Noninterest Income Other NoninterestIncomeOther	-71000	USD
CY2016Q3	us-gaap	Noninterest Income Other NoninterestIncomeOther	44000	USD
	us-gaap	Noninterest Income Other NoninterestIncomeOther	222000	USD
CY2015Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	482043000	USD
CY2016Q3	us-gaap	Notes Receivable Gross NotesReceivableGross	500848000	USD
CY2015Q3	us-gaap	Occupancy Net OccupancyNet	394000	USD
	us-gaap	Occupancy Net OccupancyNet	1176000	USD
CY2016Q3	us-gaap	Occupancy Net OccupancyNet	356000	USD
	us-gaap	Occupancy Net OccupancyNet	1131000	USD
CY2015Q4	us-gaap	Other Assets OtherAssets	10183000	USD
CY2016Q3	us-gaap	Other Assets OtherAssets	11610000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	782000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	81000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-2000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-111000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	1479000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	99000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	0	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	0	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	659000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	78000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-79000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	914000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	7000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	39000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	3000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	32000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	503000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-112000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-79000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	914000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	259000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-58000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-40000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	471000	USD
CY2015Q4	us-gaap	Other Liabilities OtherLiabilities	4333000	USD
CY2016Q3	us-gaap	Other Liabilities OtherLiabilities	6691000	USD
CY2015Q3	us-gaap	Other Noninterest Expense OtherNoninterestExpense	618000	USD
	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1746000	USD
CY2016Q3	us-gaap	Other Noninterest Expense OtherNoninterestExpense	730000	USD
	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1935000	USD
CY2014Q4	us-gaap	Other Real Estate OtherRealEstate	2102000	USD
CY2015Q3	us-gaap	Other Real Estate OtherRealEstate	1848000	USD
CY2015Q4	us-gaap	Other Real Estate OtherRealEstate	571000	USD
CY2016Q3	us-gaap	Other Real Estate OtherRealEstate	863000	USD
	us-gaap	Other Real Estate Additions OtherRealEstateAdditions	736000	USD
CY2015	us-gaap	Other Real Estate Additions OtherRealEstateAdditions	867000	USD
	us-gaap	Other Real Estate Additions OtherRealEstateAdditions	701000	USD
	us-gaap	Other Real Estate Disposals OtherRealEstateDisposals	937000	USD
CY2015	us-gaap	Other Real Estate Disposals OtherRealEstateDisposals	2110000	USD
	us-gaap	Other Real Estate Disposals OtherRealEstateDisposals	409000	USD
	us-gaap	Other Real Estate Valuation Adjustments OtherRealEstateValuationAdjustments	-53000	USD
CY2015	us-gaap	Other Real Estate Valuation Adjustments OtherRealEstateValuationAdjustments	-288000	USD
	us-gaap	Other Real Estate Valuation Adjustments OtherRealEstateValuationAdjustments	0	USD
	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	22074000	USD
	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	19701000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1540000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1623000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	21327000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	25201000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2528000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	132000	USD
	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	413000	USD
	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	22000	USD
CY2016Q3	us-gaap	Pledged Financial Instruments Not Separately Reported Securities Pledged PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledged	3000000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	10
CY2016Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	10
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2016Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	10641000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	20324000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	3424000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	6338000	USD
	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	10000	USD
	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	1000	USD
	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	856000	USD
	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	488000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	5000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	900000	USD
	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	850000	USD
CY2015Q3	us-gaap	Professional Fees ProfessionalFees	211000	USD
	us-gaap	Professional Fees ProfessionalFees	714000	USD
CY2016Q3	us-gaap	Professional Fees ProfessionalFees	266000	USD
	us-gaap	Professional Fees ProfessionalFees	775000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20964000	USD
CY2016Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20278000	USD
CY2015Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-410000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	23000	USD
CY2016Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-125000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-46000	USD
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	23000	USD
CY2015	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-227000	USD
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-46000	USD
CY2015Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	571000	USD
CY2016Q3	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	863000	USD
CY2015Q4	us-gaap	Real Estate Owned Valuation Allowance RealEstateOwnedValuationAllowance	235000	USD
CY2016Q3	us-gaap	Real Estate Owned Valuation Allowance RealEstateOwnedValuationAllowance	0	USD
	us-gaap	Real Estate Owned Valuation Allowance Provision1 RealEstateOwnedValuationAllowanceProvision1	53000	USD
	us-gaap	Real Estate Owned Valuation Allowance Provision1 RealEstateOwnedValuationAllowanceProvision1	0	USD
CY2015Q3	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	-217000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	-121000	USD
CY2016Q3	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	8000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	94000	USD
CY2015Q4	us-gaap	Restricted Investments RestrictedInvestments	1896000	USD
CY2016Q3	us-gaap	Restricted Investments RestrictedInvestments	1068000	USD
CY2015Q4	us-gaap	Time Deposits TimeDeposits	92371000	USD
CY2016Q3	us-gaap	Time Deposits TimeDeposits	88862000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	54682000	USD
CY2016Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	57125000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	227000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	220000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	23.50
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	23.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	14650	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	14650	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	23.85
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	23.07
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	15151	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	19401	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	14401	shares
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	19901	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	22.27
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	23.63
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	22.98
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	23.09
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	9363	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	8196	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	21.80
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	22.86
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	500000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1037	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	954	shares
	us-gaap	Stock Issued1 StockIssued1	551000	USD
	us-gaap	Stock Issued1 StockIssued1	499000	USD
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	24439	shares
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	21765	shares
	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan	7114	shares
	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan	2420	shares
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	9363	shares
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	8196	shares
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	551000	USD
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	499000	USD
	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	166000	USD
	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	58000	USD
	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	0	shares
	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	69104	shares
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	73132000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	77609000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	78221000	USD
CY2016Q3	us-gaap	Stockholders Equity StockholdersEquity	80707000	USD
CY2015Q3	us-gaap	Supplies And Postage Expense SuppliesAndPostageExpense	67000	USD
	us-gaap	Supplies And Postage Expense SuppliesAndPostageExpense	179000	USD
CY2016Q3	us-gaap	Supplies And Postage Expense SuppliesAndPostageExpense	68000	USD
	us-gaap	Supplies And Postage Expense SuppliesAndPostageExpense	169000	USD
	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	739000	USD
	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	707000	USD
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-170000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3532893	shares
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1385000	USD
CY2015Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2016Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3503412	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3489388	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3527725	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3532893	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3503412	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3489388	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3527725	shares
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 13. Recent Accounting Pronouncements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern”. This update is intended to provide guidance about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. Management is required under the new guidance to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date the financial statements are issued when preparing financial statements for each interim and annual reporting period. If conditions or events are identified, the ASU specifies the process that must be followed by management and also clarifies the timing and content of going concern footnote disclosures in order to reduce diversity in practice. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2016. Early adoption is permitted. The Company does not expect the adoption of ASU 2014-15 to have a material impact on its consolidated financial statements. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2016, the FASB issued ASU 2016-01, “Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities.” The amendments in ASU 2016-01, among other things: 1) Requires equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. 2) Requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes. 3) Requires separate presentation of financial assets and financial liabilities by measurement category and form of financial asset (i.e., securities or loans and receivables). 4) Eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The amendments in this ASU are effective for public companies for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company is currently assessing the impact that ASU 2016-01 will have on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842).” Among other things, in the amendments in ASU 2016-02, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: (1) A lease liability, which is a lessee‘s obligation to make lease payments arising from a lease, measured on a discounted basis; and (2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged. Certain targeted improvements were made to align, where necessary, lessor accounting with the lessee accounting model and Topic 606, Revenue from Contracts with Customers. The amendments in this ASU are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted upon issuance. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The modified retrospective approach would not require any transition accounting for leases that expired before the earliest comparative period presented. Lessees and lessors may not apply a full retrospective transition approach. The Company is currently assessing the impact that ASU 2016-02 will have on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During March 2016, the FASB issued ASU No. 2016-05, “Derivatives and Hedging (Topic 815): Effect of Derivative Contract Novations on Existing Hedge Accounting Relationships.” The amendments in this ASU clarify that a change in the counterparty to a derivative instrument that has been designated as the hedging instrument does not, in and of itself, require dedesignation of that hedging relationship provided that all other hedge accounting criteria remain intact. The amendments are effective for public business entities for financial statements issued for fiscal years beginning after December 15, 2016, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. The Company does not expect the adoption of ASU 2016-05 to have a material impact on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB issued ASU No. 2016-07, “Investments - Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting.” The amendments in this ASU eliminate the requirement that when an investment qualifies for use of the equity method as a result of an increase in the level of ownership interest or degree of influence, an investor must adjust the investment, results of operations, and retained earnings retroactively on a step-by-step basis as if the equity method had been in effect during all previous periods that the investment had been held. The amendments require that the equity method investor add the cost of acquiring the additional interest in the investee to the current basis of the investor’s previously held interest and adopt the equity method of accounting as of the date the investment becomes qualified for equity method accounting. Therefore, upon qualifying for the equity method of accounting, no retroactive adjustment of the investment is required. In addition, the amendments in this ASU require that an entity that has an available-for-sale equity security that becomes qualified for the equity method of accounting recognize through earnings the unrealized holding gain or loss in accumulated other comprehensive income at the date the investment becomes qualified for use of the equity method. The amendments are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. The amendments should be applied prospectively upon their effective date to increases in the level of ownership interest or degree of influence that result in the adoption of the equity method. Early adoption is permitted. The Company does not expect the adoption of ASU 2016-07 to have a material impact on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During March 2016, the FASB issued ASU No. 2016-09, “Compensation - Stock Compensation (Topic 718): Improvements to Employee Shares-Based Payment Accounting.” The amendments in this ASU simplify several aspects of the accounting for share-based payment award transactions including: (a) income tax consequences; (b) classification of awards as either equity or liabilities; and (c) classification on the statement of cash flows. The amendments are effective for public companies for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company is currently assessing the impact that ASU 2016-09 will have on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” The amendments in this ASU, among other things, require the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. Many of the loss estimation techniques applied today will still be permitted, although the inputs to those techniques will change to reflect the full amount of expected credit losses. In addition, the ASU amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. The amendments in this ASU are effective for SEC filers for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company is currently assessing the impact that ASU 2016-13 will have on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During August 2016, the FASB issued ASU No. 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments”, to address diversity in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The amendments are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The amendments should be applied using a retrospective transition method to each period presented. If retrospective application is impractical for some of the issues addressed by the update, the amendments for those issues would be applied prospectively as of the earliest date practicable.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">Early adoption is permitted, including adoption in an interim period. The Company does not expect the adoption of ASU 2016-15 to have a material impact on its consolidated financial statements.</font></div></div>

Files In Submission

Name	View Source	Status
0000880641-16-000183-index-headers.html	Edgar Link	pending
0000880641-16-000183-index.html	Edgar Link	pending
0000880641-16-000183.txt	Edgar Link	pending
0000880641-16-000183-xbrl.zip	Edgar Link	pending
efsi-20160930.xml	Edgar Link	completed
efsi-20160930.xsd	Edgar Link	pending
efsi-20160930exhibit311.htm	Edgar Link	pending
efsi-20160930exhibit312.htm	Edgar Link	pending
efsi-20160930exhibit321.htm	Edgar Link	pending
efsi-20160930x10q.htm	Edgar Link	pending
efsi-20160930_cal.xml	Edgar Link	unprocessable
efsi-20160930_def.xml	Edgar Link	unprocessable
efsi-20160930_lab.xml	Edgar Link	unprocessable
efsi-20160930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EFSI
EAGLE FINANCIAL SERVICES INC Stock $efsi

2016 Q4 Form 10-Q Financial Statement

#000088064116000183 Filed on November 14, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EFSI EAGLE FINANCIAL SERVICES INC Stock $efsi

2016 Q4 Form 10-Q Financial Statement

#000088064116000183 Filed on November 14, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EFSI
EAGLE FINANCIAL SERVICES INC Stock $efsi